Allspring Global Investments Holdings LLC increased its holdings in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 2,194.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 105,688 shares of the company's stock after acquiring an additional 101,082 shares during the period. Allspring Global Investments Holdings LLC owned about 0.05% of DocuSign worth $6,562,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in DOCU. Inspire Investing LLC bought a new stake in DocuSign in the 3rd quarter worth about $911,000. Comerica Bank grew its position in DocuSign by 228.8% in the 1st quarter. Comerica Bank now owns 28,901 shares of the company's stock worth $1,721,000 after purchasing an additional 20,110 shares in the last quarter. Retirement Systems of Alabama bought a new stake in DocuSign in the 1st quarter worth about $8,700,000. PGGM Investments grew its position in DocuSign by 36.7% in the 2nd quarter. PGGM Investments now owns 49,812 shares of the company's stock worth $2,665,000 after purchasing an additional 13,379 shares in the last quarter. Finally, Claro Advisors LLC bought a new stake in DocuSign in the 3rd quarter worth about $727,000. Institutional investors and hedge funds own 77.64% of the company's stock.
Insider Buying and Selling at DocuSign
In other DocuSign news, insider Robert Chatwani sold 14,799 shares of the business's stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.46, for a total value of $820,752.54. Following the transaction, the insider now owns 70,748 shares in the company, valued at approximately $3,923,684.08. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other DocuSign news, insider Robert Chatwani sold 14,799 shares of the business's stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.46, for a total value of $820,752.54. Following the transaction, the insider now owns 70,748 shares in the company, valued at approximately $3,923,684.08. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Teresa Briggs sold 534 shares of the business's stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $56.56, for a total transaction of $30,203.04. Following the transaction, the director now owns 7,202 shares in the company, valued at $407,345.12. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 427,554 shares of company stock worth $23,129,150. 1.66% of the stock is currently owned by company insiders.
DocuSign Stock Up 0.9 %
Shares of NASDAQ DOCU traded up $0.59 during mid-day trading on Monday, reaching $69.58. 1,651,126 shares of the company were exchanged, compared to its average volume of 2,927,141. The stock has a market capitalization of $14.24 billion, a PE ratio of 132.67, a PEG ratio of 7.33 and a beta of 0.92. The company's 50 day moving average price is $61.87 and its 200 day moving average price is $57.63. DocuSign, Inc. has a 52 week low of $38.11 and a 52 week high of $73.80.
DocuSign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, September 5th. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.80 by $0.17. The company had revenue of $736.03 million for the quarter, compared to analysts' expectations of $727.20 million. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The firm's revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.09 EPS. On average, sell-side analysts predict that DocuSign, Inc. will post 1.01 earnings per share for the current year.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. Bank of America upped their price objective on shares of DocuSign from $60.00 to $68.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Wells Fargo & Company increased their target price on shares of DocuSign from $48.00 to $50.00 and gave the company an "underweight" rating in a research report on Friday, September 6th. JMP Securities reissued a "market outperform" rating and set a $84.00 target price on shares of DocuSign in a research report on Thursday, September 5th. Robert W. Baird lifted their price objective on shares of DocuSign from $55.00 to $59.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. Finally, Citigroup raised their price target on shares of DocuSign from $86.00 to $87.00 and gave the company a "buy" rating in a report on Friday, September 6th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, DocuSign currently has an average rating of "Hold" and an average price target of $63.40.
Read Our Latest Stock Analysis on DOCU
DocuSign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.